期刊
CLINICAL KIDNEY JOURNAL
卷 14, 期 11, 页码 2295-2303出版社
OXFORD UNIV PRESS
DOI: 10.1093/ckj/sfab072
关键词
bupropion; kidney transplantation; nicotine replacement therapy; smoking cessation; varenicline
Smoking has negative impacts on kidney transplantation outcomes, with guidelines strongly recommending quitting before transplantation. Nicotine addiction is a complex disease, with smoking cessation programmes proving effective in the general population.
Tobacco smoking is a frequent problem affecting many kidney transplant (KT) candidates and recipients. The negative impact of active smoking on KT outcomes has been demonstrated. Consequently, most guidelines strongly recommend quitting smoking before considering kidney transplantation. However, nicotine addiction is a complex multifactorial disease and only 3-5% of the patients who try to quit by themselves achieve prolonged abstinence. Smoking cessation programmes (SCPs) have proven their efficacy in the general population to increase the rate of quitting and should therefore be proposed to all smoking KT candidates and recipients. Nevertheless, SCPs have not been evaluated in the KT field and not all KT centres have easy access to these programmes. In this work, we aim to review the current knowledge on the subject and provide an overview of the available interventions to help smoking patients quit. We detail non-pharmaceutical and pharmaceutical approaches and discuss their use in KT candidates and recipients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据